港股異動丨香港科技探索創約一年半新低 此前發盈警 大行唱空
格隆匯12月2日丨香港科技探索(1137.HK)跌逾5%,報8.28港元,低見8.21港元創約一年半新低,總市值76億港元。前9月公司錄得未經審核盈利1.863億港元,同比下跌約78.5%。因此公司預計,2021年年度的盈利及經調整後的扣除利息、税項、折舊及攤銷前盈利將會取得顯著下降。大和隨後發佈研報稱,香港科技探索發盈警,意味着全年調整後EBITDA表現最終可能遜於管理層早前30%增長指引,建議投資者等待更好的入市機會,但該行預計其股價在12個月內仍將跑贏大市,將評級由“買入”下調至“跑贏大市”。目標價相應由14港元下調至11港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.